Surrozen, Inc. (SRZN)
NASDAQ: SRZN · Real-Time Price · USD
28.15
-1.72 (-5.76%)
May 15, 2026, 4:00 PM EDT - Market closed
Surrozen Market Cap
Surrozen has a market cap or net worth of $323.35 million as of May 15, 2026. Its market cap has increased by 263.22% in one year.
Market Cap
323.35M
Enterprise Value
223.22M
1-Year Change
263.22%
Ranking
Category
Stock Price
$28.15
Market Cap Chart
Since January 11, 2021, Surrozen's market cap has increased from $120.65M to $323.35M, an increase of 168.00%. That is a compound annual growth rate of 20.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 323.35M | 53.47% |
| Dec 31, 2025 | 210.69M | 351.80% |
| Dec 31, 2024 | 46.63M | 143.39% |
| Dec 29, 2023 | 19.16M | 10.72% |
| Dec 30, 2022 | 17.31M | -92.33% |
| Dec 31, 2021 | 225.58M | 86.96% |
| Jan 11, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Fennec Pharmaceuticals | 338.69M |
| Neumora Therapeutics | 336.15M |
| Compass Therapeutics | 334.96M |
| Immuneering | 333.84M |
| Atea Pharmaceuticals | 328.11M |
| DiaMedica Therapeutics | 327.07M |
| Nautilus Biotechnology | 318.97M |
| OmniAb | 316.04M |